The CCK8 assay demonstrated significant inhibition of colon cancer cell growth with JOSD1 deletion (Fig. 2E, F), while the EdU doping assay revealed a marked decrease in colon cancer cell proliferation due to JOSD1 deletion (Fig. 2G–J). Here, JOSD1 is linked to colonic neoplasm.